Back to Directory
Last Updated: 03/06/2026
Synthace
London
Founded 2011
No-code digital experiment platform for life science R&D
Synthace provides cloud-based software that enables life science researchers to design, automate and analyse experiments without writing code.
Its platform integrates with laboratory automation hardware, structures experimental data and applies design of experiments methodologies, with a primary focus on assay development and bioprocess optimisation.
The company raised a $35 million Series C and announced a collaboration with Charles River Laboratories in February 2026 to advance assay development across multiple laboratories.